Insulin glargine and acarbose in the treatment of type II diabetes
Phase 2
- Conditions
- Diabet mellitus.non insulin dependent diabetes mellitus
- Registration Number
- IRCT201403041774N6
- Lead Sponsor
- Physiology research center, Vice chancellor for Research and Technology of kerman medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 152
Inclusion Criteria
1. Type 2 diabetes (based on American Diabetes Association criteria)
2. age group 18-75 years
3. Enough acuity and alertness to injection of insulin
4. no glycemic control with oral medications
Exclusion criteria:
1. Chronic Complications of Diabetes
2. Pregnancy
3. Breastfeeding
4. Liver Disease
5. kidney disease
6. neurological disease
7. chronic inflammatory disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma glucose. Timepoint: During of study. Method of measurement: Blood sample.;HbA1c. Timepoint: 0, 90. Method of measurement: Blood sample.;Hypoglycemia. Timepoint: Self - monitoring of blood glucose. Method of measurement: Questionnaire and blood tests during raid.
- Secondary Outcome Measures
Name Time Method aboratory Tests. Timepoint: Before and one month, two months, three months after the intervention. Method of measurement: blood and urine sample.;Weight and blood prussre and others. Timepoint: Before and one month, two months, three months after the intervention. Method of measurement: Barometer system and standard weight.